Medium-term outcomes of Boston type 1 keratoprosthesis implantation in Bangkok, Thailand

Cornea

Volumn 33, Issue 12, 2014, Pages 1312-1319

  Lekhanont, Kaevalin ^a   Thaweesit, Panyachat ^a   Muntham, Dittapol ^a   Chuckpaiwong, Varintorn ^a   Vongthongsri, Anun ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Boston keratoprosthesis; Complications; Medium term outcomes

Indexed keywords

ANTIBIOTIC AGENT; ANTIGLAUCOMA AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CORNEA INJURY; CORNEA MELTING; ENDOPHTHALMITIS; EPIRETINAL MEMBRANE; EXPLANT; FOLLOW UP; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; INFECTION PREVENTION; INTERVENTION STUDY; INTRAOCULAR PRESSURE; KERATITIS; KERATOPROSTHESIS; OCULOPLETHYSMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT REFERRAL; PENETRATING KERATOPLASTY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROSTHESIS FAILURE; PROSTHESIS IMPLANTATION; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETROPROSTHETIC MEMBRANE FORMATION; SOUTHEAST ASIA; SPECTACLES; THAILAND; UNIVERSITY; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE; BIOPROSTHESIS; CORNEA; CORNEAL DISEASES; FEMALE; GRAFT SURVIVAL; MALE; MIDDLE AGED; PHYSIOLOGY; PROSTHESES AND ORTHOSES; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BIOPROSTHESIS; CHILD; CORNEA; CORNEAL DISEASES; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; THAILAND; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84927614619     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000265     Document Type: Article

References (39)

1. Zerbe BL, Belin MW, Ciolino JB; Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston type 1 keratoprosthesis study. Ophthalmology. 2006;113:1779-1784.
2. Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28:989-996.
3. Dunlap K, Chak G, Aquavella JV, et al. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. Ophthalmology. 2010;117:687-692.
4. Robert MC, Harissi-Dagher M. Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol. 2011;46:164-168.
5. Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011;118:1543-1550.
6. Patel AP, Wu EI, Ritterband DC, et al. Boston type 1 keratoprosthesis: the New York Eye and Ear experience. Eye. 2012;26:418-425.
7. Kamyar R, Weizer JS, de Paula FH, et al. Glaucoma associated with Boston type I keratoprosthesis. Cornea. 2012;31:134-139.
8. Ciolino JB, Belin MW, Todani A, et al; Boston Keratoprosthesis Type 1 Study Group. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2013;120:1195-1200.
9. Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119:1530-1538.
10. Iyer G, Srinivasan B, Gupta N, et al. Outcome of Boston keratoprosthesis in a developing country-importance of patient selection, education, and perioperative care: the Indian experience. J Ophthalmol. 2012;1:202-207.
11. Shihadeh WA, Mohidat HM. Outcomes of the Boston keratoprosthesis in Jordan. Middle East Afr J Ophthalmol. 2012;19:97-100.
12. Verdejo-Gómez L, Peláez N, Gris O, et al. The Boston type I keratoprosthesis: an assessment of its efficacy and safety. Ophthalmic Surg Lasers Imaging. 2011;42:446-452.
13. Muñoz-Gutierrez G, Alvarez de Toledo J, Barraquer RI, et al. Post-surgical visual outcome and complications in Boston type 1 keratoprosthesis. Arch Soc Esp Oftalmol. 2013;88:56-63.
14. Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea. 2001;20:19-23.
15. Ciralsky J, Papaliodis GN, Foster CS, et al. Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm. 2010;18:275-280.
16. Ciralsky JB, Sippel KC, Gregory DG. Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal necrolysis. Curr Opin Ophthalmol. 2013;24:321-328.
17. Lekhanont K, Panday V, Akpek EK. Permanent keratoprostheses. In: Brightbill FS, ed. Corneal Surgery: Theory, Technique, and Tissue. St Louis, MO: Mosby; 2009:683-690.
18. Waller SG, Dohlman CH. The Boston keratoprosthesis. In: Brightbill FS, ed. Corneal Surgery: Theory, Technique, and Tissue. St Louis, MO: Mosby; 2009:691-696.
19. Aldave AJ, Kamal KM, Vo RC, et al. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116:640-651.
20. Bradley JC, Hernandez EG, Schwab IR, et al. Boston type 1 keratoprosthesis: the university of California Davis experience. Cornea. 2009;28:321-327.
21. Harissi-Dagher M. Boston keratoprosthesis: expanding the boundaries. Digit J Ophthalmol. 2011;17:53-54.
22. Talajic JC, Agoumi Y, Gagné S, et al. Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery. Am J Ophthalmol. 2012;153:267-274.
23. Robert MC, Pomerleau V, Harissi-Dagher M. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices. Br J Ophthalmol. 2013;97:573-577.
24. Netland PA, Terada H, Dohlman CH. Glaucoma associated with keratoprosthesis. Ophthalmology. 1998;105:751-757.
25. Rivier D, Paula JS, Kim E, et al. Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma. 2009;18:321-324.
26. Panarelli JF, Ko A, Sidoti PA, et al. Angle closure after Boston keratoprosthesis. J Glaucoma. 2013;22:725-729.
27. Sivaraman KR, Hou JH, Allemann N, et al. Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston keratoprosthesis. Am J Ophthalmol. 2013;155:814-822.
28. Chak G, Aquavella JV. A safe Nd: YAG retroprosthetic membrane removal technique for keratoprosthesis. Cornea. 2010;29:1169-1172.
29. Rudnisky CJ, Belin MW, Todani A, et al; Boston Type 1 Keratoprosthesis Study Group. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2012;119:951-955.
30. Utine CA, Tzu JH, Akpek EK. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt. Ocul Immunol Inflamm. 2011;19:413-418.
31. Sayegh RR, Ang LP, Foster CS, et al. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol. 2008;145:438-444.
32. Chan CC, Holland EJ. Infectious keratitis after Boston type 1 keratoprosthesis implantation. Cornea. 2012;31:1128-1134.
33. Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea. 2007;26:9-15.
34. Ramchandran RS, Diloreto DA Jr, Chung MM, et al. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis. Ophthalmology. 2012;119:674-681.
35. Chan CC, Holland EJ. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea. 2012;31:346-349.
36. Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012;96:776-780.
37. Garcia JP Jr, Ritterband DC, Buxton DF, et al. Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography. Cornea. 2010;29:1031-1035.
38. Magalhães FP, do Nascimento HM, Ecker DJ, et al. Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine. Cornea. 2013;32:407-411.
39. Jain V, Mhatre K, Shome D, et al. Fungal keratitis with the type 1 Boston keratoprosthesis: early Indian experience. Cornea. 2012;31:841-843.